Trending
Subscribe & Follow
Advertise your job vacancies
Jobs
- Warranty Assessor George
- Data Scientist Johannesburg
- Marketing Manager Johannesburg
- Senior Art Director Sandton
- Group Head of Marketing Umhlanga
- Full Stack PHP JavaScript Developer – Cape Town / Hybrid – R850k PA Cape Town
- Head of Marketing Durban
- Head AI and Data Engineer Cape Town
- Creative Lead Johannesburg
- Procurement Officer Johannesburg
Nestlé to acquire biopharmaceutical company Aimmune
Nestlé Health Science (NHSc) is to acquire Aimmune Therapeutics in accordance with a definitive agreement between Nestlé and the biopharmaceutical company.
NHSc currently has a total investment in Aimmune of $473m, an approximate 25.6% equity ownership stake. The company made its initial investment of $145m in Aimmune in November 2016, followed by further investments of $30m in February 2018, $98m in November 2018 and $200m in January 2020.
